OMEROS CORPORATION

Lobbying client · Washington · filed 2025 to 2025

Biopharmaceutical company focused on small-molecule and protein therapeutics.

$45,000 Reported spend

2 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (206632), not by name.

Firms hired 1

GRAYROBINSON PA $45,000 2 filings

Reported by year 1 year

2025 $45,000 2 filings

Issues lobbied 1

Medicare/Medicaid 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Executive Office of the President (EOP) 1
HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 2 total

2TY

GRAYROBINSON PA

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 18, 2025

View → Q1

GRAYROBINSON PA

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $45,000 income · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.